SEC Form 4 · accession 0001209191-15-035100
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Adams
Officer — VP and General Counsel
Period of report
Apr 15, 2015
Accepted (ET)
Apr 17, 2015 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 15, 2015 | S | 4,320 | $12.40 | D | 59,555 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of a total of 4,320 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 13,334 shares of restricted stock on April 14, 2015. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- F2Includes 50,541 shares of restricted stock.